Open access · OA
via OpenAlex
Telomere Length and Risk of Incident Cancer and Cancer Mortality
Peter Willeit, Johann Willeit, Agnes Mayr, Siegfried Weger, Friedrich Oberhollenzer, Anita Kloss‐Brandstätter, Florian Kronenberg, Stefan Kiechl
JAMA · 2010 · ▲ 484 citations
Abstract
CONTEXT: Telomeres are essential to preserve the integrity of the genome. Critically short telomeres lead to replicative cell senescence(definition) and chromosomal instability and may thereby increase cancer risk. OBJECTIVE: To determine the association between baseline telomere(definition) length and incident cancer and cancer mortality. DESIGN, SETTING, AND PARTICIPANTS: Leukocyte telomere length was measured by quantitative polymerase chain reaction in 787 participants free of cancer at baseline in 1995 from the prospective, population-based Bruneck Study in Italy. MAIN OUTCOME MEASURES: Incident cancer and cancer mortality over a follow-up period of 10 years (1995-2005 with a follow-up rate of 100%). RESULTS: A total of 92 of 787 participants (11.7%) developed cancer (incidence rate, 13.3 per 1000 person-years). Short telomere length at baseline was associated with incident cancer independently of standard cancer risk factors (multivariable hazard ratio [HR] per 1-SD decrease in log(e)-transformed telomere length, 1.60; 95% confidence interval [CI], 1.30-1.98; P < .001). Compared with participants in the longest telomere length group, the multivariable HR for incident cancer was 2.15 (95% CI, 1.12-4.14) in the middle length group and 3.11 (95% CI, 1.65-5.84) in the shortest length group (P < .001). Incidence rates were 5.1 (95% CI, 2.9-8.7) per 1000 person-years in the longest telomere length group, 14.2 (95% CI, 10.0-20.1) per 1000 person-years in the middle length group, and 22.5 (95% CI, 16.9-29.9) per 1000 person-years in the shortest length group. The association equally applied to men and women and emerged as robust under a variety of circumstances. Furthermore, short telomere length was associated with cancer mortality (multivariable HR per 1-SD decrease in log(e)-transformed telomere length, 2.13; 95% CI, 1.58-2.86; P < .001) and individual cancer subtypes with a high fatality rate. CONCLUSION: In this study population, there was a statistically significant inverse relationship between telomere length and both cancer incidence and mortality.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1001/jama.2010.897
- Canonical
- link ↗
- Fetched
- 2026-06-02 MST
Cite this
APA
Willeit, P., Willeit, J., Mayr, A., Weger, S., Oberhollenzer, F., Kloss‐Brandstätter, A., Kronenberg, F., & Kiechl, S. (2010). Telomere Length and Risk of Incident Cancer and Cancer Mortality. <em>JAMA</em>. https://doi.org/10.1001/jama.2010.897
Vancouver
Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, Kloss‐Brandstätter A, et al. Telomere Length and Risk of Incident Cancer and Cancer Mortality. JAMA. 2010. doi:10.1001/jama.2010.897.
BibTeX
@article{peter2010Telome,
title = {Telomere Length and Risk of Incident Cancer and Cancer Mortality},
author = {Peter Willeit and Johann Willeit and Agnes Mayr and Siegfried Weger and Friedrich Oberhollenzer and Anita Kloss‐Brandstätter and Florian Kronenberg and Stefan Kiechl},
journal = {JAMA},
year = {2010},
doi = {10.1001/jama.2010.897},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
JNCI Journal of the National Cancer Institute 2003
Open access · OA
Telomere Dysfunction: A Potential Cancer Predisposition Factor
Trends in cancer 2017
Preprint · OA
Mutations, Cancer and the Telomere Length Paradox
Aging 2018
Preprint · OA
Longitudinal changes in leukocyte telomere length and mortality in elderly Swedish men
Cancer Epidemiology Biomarkers & Prevention 2011
Open access · OA
The Association of Telomere Length and Cancer: a Meta-analysis
PLoS ONE 2011
Open access · CC-BY
Shortened Telomere Length Is Associated with Increased Risk of Cancer: A Meta-Analysis
JAMA Oncology 2017
Open access · OA